1211444

Andrew C. Siesennop, MD — FEI 3026483028

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 4, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Boston, MA (United States)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance